Irinotecan plus leucovorin-modulated 5-fluorouracil I.V. bolus every other week may be a suitable therapeutic option also for elderly patients with metastatic colorectal carcinoma

The aim of this study was to assess the safety and efficacy of biweekly irinotecan plus leucovorin-modulated 5-fluorouracil i.v. bolus in metastatic colorectal carcinoma according to the age of patients. For this purpose, we have analysed 108 patients randomly allocated to receive irinotecan 200 mg ...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Comella, P, Farris, A, Lorusso, V, Palmeri, S, Maiorino, L, Lucia, L De, Buzzi, F, Mancarella, S, Vita, F De, Gambardella, A
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 2003
Onderwerpen:
Clinical
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2376956/
https://ncbi.nlm.nih.gov/pubmed/12966414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6601214
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items